Spero Therapeutics
SPRO | NASDAQ
$0.93
-$0.07 (-6.99%)
At close: Nov 16, 2026, 3:59 PM ET
$0.93
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-6.99%
(1D)No price chart data available for 1D timeframe.
Rating
37.5
+5.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #598/1021 (Top 59%)
Key Statistics
Market Data
Market Cap $54.3M
1D Range
0.90 0.99
52W Range
0.90 2.98
Valuation (TTM)
PE -1.79
PB 69.52
EV/EBITDA -6.41
Valuation (NTM)
Forward PE 1.65
Forward PEG -0.00
Price Target $6.00
Cash Flow
FCF Yield -74.5%
SBC Adj. FCF Yield -81.5%
SBC Impact -9.4%
Margins
Gross Margin 100.0%
Operating Margin 17.6%
FCF Margin -101.3%
Growth (CAGR)
Revenue 3Y | 5Y -19.5% |
27.1%
Dil EPS 3Y | 5Y -70.8% |
51.2%
FCF 3Y | 5Y -40.1% |
8.0%
Returns
ROA -26.8%
ROE -75.2%
ROIC 12.9%
Financial Health
Net Cash
$107.93M
Current Ratio 1.92
Interest Coverage 2.14
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant ...
Sector Healthcare
Industry Biotechnology
Employees 25
IPO Date Nov 2, 2017
Website sperotherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+545.16%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SPRO